For most of the last decade, predicting the direction of Medicare was relatively easy.
Medicare Advantage enrollment would grow. Insurance companies would expand into more counties. Benefits would become richer. Zero-premium plans would multiply. Dental allowances would increase. Over-the-counter benefits would get bigger. And every October, Medicare beneficiaries would open their mailboxes to find another stack of advertisements promising more benefits.
That formula worked remarkably well.
But as we approach 2027, something has changed.
Medicare Advantage isn’t collapsing. It isn’t disappearing. And despite some of the headlines circulating around the industry, Original Medicare isn’t suddenly taking back the market.
Instead, Medicare appears to be entering a period of maturity, consolidation and financial discipline.
For beneficiaries, that could mean fewer plans in some markets, changing provider networks, higher cost sharing and supplemental benefits that aren’t quite as generous as they once were.
For insurance agents and brokers, it means the job is becoming more complicated — and arguably more important.
And for the insurance companies themselves, 2027 may be another year where profitability matters more than simply adding another million members.
Medicare Advantage Is Still Dominant
It is important to put the current Medicare Advantage conversation into perspective.
More than 35 million Americans are enrolled in Medicare Advantage in 2026, representing approximately 55% of Medicare beneficiaries eligible to enroll in MA.
That’s an extraordinary transformation.
In 2007, only about 19% of eligible Medicare beneficiaries were enrolled in Medicare Advantage. Today, more than half are.
The difference is that growth is slowing.
Medicare Advantage enrollment increased by roughly 3% between 2025 and 2026. That’s still growth, but it is considerably slower than the roughly 7% to 10% annual increases that became common during much of the previous decade.
That distinction matters.
Slower growth is not the same thing as decline.
Medicare Advantage has become such a large portion of Medicare that maintaining the explosive growth rates of the past becomes mathematically difficult. And according to Congressional Budget Office projections cited by KFF, Medicare Advantage could eventually reach approximately 63% of eligible beneficiaries by 2034.
The long-term story may therefore still favor Medicare Advantage.
The short-term story is considerably messier.
The Benefit Arms Race Is Cooling
For years, Medicare Advantage carriers competed aggressively on supplemental benefits.
Dental.
Vision.
Hearing.
OTC cards.
Transportation.
Meals.
Fitness memberships.
And eventually combinations of benefits that would have seemed almost unimaginable 15 years ago.
That competition was great for consumers.
But benefits cost money.
Healthcare utilization has increased, medical expenses have risen, and insurers have faced pressure from changes to Medicare’s risk-adjustment system. At some point, the economics have to work.
CMS finalized an average 2.48% increase in Medicare Advantage payments for 2027, representing more than $13 billion in additional payments to plans. When estimated coding trends are included, CMS says the increase is approximately 4.98%.
That sounds substantial.
Insurance companies, however, must balance those payments against medical cost trends, utilization, Star Ratings, risk adjustment changes and the increasingly expensive supplemental benefits consumers have become accustomed to receiving.
The result is likely to be continued pressure on benefits.
We should not expect every Medicare Advantage plan to suddenly become worse in 2027. Some markets will remain extremely competitive, and certain carriers will undoubtedly introduce attractive new plans.
But the broader direction appears clear:
The days when carriers could simply add another $500 to the dental allowance to win market share are becoming harder to sustain.
Expect More Strategic Carrier Exits
Another trend that could become increasingly visible in 2027 is geographic retrenchment.
Insurance companies have spent years expanding their Medicare Advantage footprints.
Now some are doing the opposite.
Rather than trying to participate everywhere, insurers are increasingly examining Medicare Advantage county by county.
Is the provider network competitive?
Can the plan achieve acceptable Star Ratings?
What does utilization look like?
What does the risk pool look like?
Can the carrier make money?
If the answer to those questions isn’t attractive enough, carriers are becoming more willing to leave.
Humana, for example, has indicated that its 2027 Medicare Advantage reductions could affect roughly 600,000 members as it pulls back from certain markets. Other insurers have also been reducing or exiting portions of their Medicare Advantage footprints.
That doesn’t necessarily mean fewer choices everywhere.
Medicare remains an enormous and highly competitive market.
But the strategy is changing.
Instead of growth at almost any cost, we are seeing something closer to profitable growth in the right markets.
That is a very different business model.
Special Needs Plans Are Becoming a Bigger Part of Medicare Advantage
One of the most important Medicare trends receives considerably less attention than shrinking dental allowances.
Special Needs Plans are exploding.
Nearly 8.2 million beneficiaries were enrolled in SNPs in 2026, representing approximately 23% of Medicare Advantage enrollment. Even more striking, SNPs accounted for roughly 85% of the net increase in Medicare Advantage enrollment between 2025 and 2026.
That is not a small trend.
It represents a structural shift in the market.
Dual Eligible Special Needs Plans (D-SNPs) continue to represent the majority of SNP enrollment, while Chronic Condition Special Needs Plans (C-SNPs) are also expanding rapidly.
In fact, C-SNP enrollment increased approximately 45% between 2025 and 2026.
That tells us something about where insurers see opportunity.
The future of Medicare Advantage may increasingly involve more targeted plan design rather than simply creating one broad PPO or HMO designed to appeal to everyone turning 65.
Plans designed around diabetes, cardiovascular disease, chronic heart failure and dual eligibility can potentially offer benefits specifically tailored to those populations.
For Medicare insurance agents, understanding SNP eligibility is therefore becoming increasingly important.
Part D Could Be One of the Biggest Stories of 2027
Prescription drug coverage has undergone some of the largest changes since Medicare Part D was created.
The Inflation Reduction Act fundamentally redesigned the Part D benefit.
The old coverage gap — commonly called the “donut hole” — has effectively disappeared. Beneficiary liability in the catastrophic phase has been eliminated, and the redesigned benefit dramatically limits how much someone can be required to spend out-of-pocket for covered Part D prescriptions.
CMS’s 2027 final rule codifies these changes into the program going forward.
That’s good news for beneficiaries taking expensive medications.
But there is another side to the story.
The cost doesn’t simply disappear.
It gets redistributed among Medicare, drug manufacturers and insurance companies.
And insurers price that risk into their plans.
For 2027, the Medicare Part D national average monthly bid amount will increase to $296.05, while the Part D base beneficiary premium rises from $38.99 in 2026 to $41.33 in 2027. The base beneficiary premium increase is limited by the Inflation Reduction Act’s premium stabilization mechanism.
That does not mean every beneficiary will pay $41.33.
Actual Part D premiums vary significantly by plan and geography.
But the underlying numbers show the financial pressure building inside the Part D system.
For consumers, this makes annual plan reviews even more important.
A drug plan that worked perfectly in 2026 may not necessarily be the best plan in 2027.
Premiums can change.
Formularies can change.
Preferred pharmacies can change.
Drug tiers can change.
And sometimes the cheapest-looking plan isn’t actually the cheapest plan once prescriptions are entered.
Medicare Supplement May Quietly Become More Attractive
One interesting side effect of Medicare Advantage becoming less generous could be renewed interest in Medicare Supplement insurance.
For years, Medicare Advantage had an incredibly easy marketing story:
Low or zero monthly premiums.
Dental.
Vision.
Hearing.
Prescription coverage.
OTC benefits.
Gym memberships.
Sometimes transportation, meals and other benefits.
Medicare Supplement takes a different approach.
You generally pay a monthly premium in exchange for predictable medical costs and broad access to providers who accept Medicare.
If Medicare Advantage supplemental benefits continue tightening while copays and maximum out-of-pocket limits increase, the comparison between the two systems becomes more nuanced.
For some beneficiaries, Medicare Advantage will still make tremendous sense.
For others, paying more upfront for a Medicare Supplement may become increasingly attractive.
That doesn’t mean Medicare Supplement is automatically better.
Medigap premiums generally increase as people age, underwriting rules can make switching later difficult in many states, and beneficiaries usually need separate Part D coverage.
The important trend is choice.
The Medicare market is becoming complicated enough that simply asking, “Which plan has the biggest dental benefit?” is increasingly inadequate.
Star Ratings Are Becoming Even More Important
Star Ratings have always mattered.
Going forward, they may matter even more.
CMS is changing the Medicare Advantage and Part D Star Ratings system for 2027, including removing 11 measures that were largely focused on administrative processes or areas where CMS believed there was little meaningful difference between plans.
The system is being refocused more heavily toward clinical care, health outcomes and patient experience.
That’s significant because Star Ratings aren’t merely something beneficiaries see on Medicare.gov.
They affect money.
Higher-performing Medicare Advantage contracts can qualify for quality bonus payments that can help finance richer benefits.
In a tighter Medicare Advantage environment, those dollars become increasingly valuable.
A carrier capable of managing healthcare costs while maintaining strong Star Ratings has considerably more flexibility than one struggling on both fronts.
That could eventually produce an interesting divide between winners and losers in the Medicare Advantage market.
Risk Adjustment Isn’t Going Away
Risk adjustment will continue to be one of the most important — and least understood — forces shaping Medicare Advantage.
CMS fully implemented the 2024 Medicare Advantage risk-adjustment model in 2026. CMS initially proposed another model update for 2027 but ultimately decided to continue using the 2024 model, giving the market additional time to adjust.
However, CMS is making other changes.
For 2027, diagnoses from audio-only encounters will be excluded from risk-score calculations, and CMS is generally excluding diagnoses submitted through unlinked chart review records, with a limited exception involving beneficiaries switching between Medicare Advantage organizations.
This sounds incredibly technical.
And it is.
But the consequences eventually reach consumers.
Risk adjustment affects how much Medicare pays an insurance company to cover a beneficiary.
Change the methodology and you change the economics.
Change the economics and eventually you can change premiums, copays, benefits, networks and even whether an insurance company chooses to offer a plan in a particular county.
Medicare’s Financial Problem Hasn’t Disappeared
There is also a much larger issue hanging over all of this.
Medicare itself is under increasing financial pressure.
The 2026 Medicare Trustees Report projects that the Hospital Insurance Trust Fund — which finances Medicare Part A — will be depleted in the second quarter of 2033 under current projections.
That does not mean Medicare disappears in 2033.
It does mean Medicare faces a long-term financing problem that eventually has to be addressed.
Politicians can argue about how.
Higher taxes.
Lower payments.
Benefit changes.
Eligibility changes.
More aggressive cost controls.
Drug pricing reforms.
Or some combination of all of them.
But eventually the math wins.
An aging population combined with rising healthcare costs makes Medicare one of the most important fiscal issues facing the country.
That means the pressure we’re seeing in Medicare Advantage today probably isn’t temporary.
The system is being asked to provide increasingly sophisticated healthcare to an enormous aging population while controlling what taxpayers and beneficiaries are required to spend.
There are no easy answers.
The Independent Medicare Broker May Become More Important, Not Less
Technology is making Medicare easier to shop.
But ironically, the plans themselves are becoming harder to understand.
A beneficiary can compare premiums online in seconds.
What is much harder is understanding whether their cardiologist participates in a particular HMO, whether their insulin is preferred on the formulary, whether they qualify for a C-SNP, whether their Medicare Supplement application will pass underwriting, or whether a $0-premium Medicare Advantage plan actually makes sense for their situation.
That’s where the role of the independent Medicare broker changes.
The future probably isn’t simply selling Medicare plans.
It is understanding Medicare.
There is a difference.
The agent who knows one carrier and sells one product is increasingly vulnerable.
The broker who understands Medicare Advantage, Medicare Supplement, Part D, provider networks, formularies, underwriting, Special Needs Plans and the differences between carriers becomes increasingly valuable.
And 2027 could make that distinction much clearer.
2027 Could Be the Beginning of Medicare’s Next Era
There is a temptation whenever Medicare Advantage carriers reduce benefits or exit markets to declare that Medicare Advantage is in trouble.
That conclusion goes too far.
More than half of eligible Medicare beneficiaries are already enrolled in Medicare Advantage. Enrollment is still growing. SNP enrollment is growing rapidly. And insurers are still competing aggressively for Medicare beneficiaries.
But something is changing.
The industry is maturing.
Carriers are becoming more selective.
Benefits are being scrutinized.
Risk adjustment is becoming tighter.
Part D economics are changing.
Star Ratings are becoming increasingly important.
And beneficiaries may have to look more carefully at their coverage each year.
The Medicare market of 2027 will probably still look familiar.
There will still be $0-premium Medicare Advantage plans. There will still be dental benefits. There will still be Medicare Supplements. There will still be Part D plans. And there will still be plenty of television commercials every fall.
But underneath all of that, the economics are changing.
For beneficiaries, that makes complacency dangerous.
For insurance carriers, it makes discipline necessary.
And for insurance agents and brokers, it creates opportunity.
Because the more complicated Medicare becomes, the more valuable good advice becomes.
Maybe that’s the biggest Medicare trend heading into 2027.
The product is becoming harder to sell based on benefits alone — and easier to sell based on knowledge.
